AIREST

Multimodal digital biomarkers for evidence-based mental health decision support and monitoring

A SaMD platform designed to accelerate screening and provide objective insights for clinicians, patients, and health systems.

Product mock

Face mesh

Audio signal

Text features

Model output

The crisis in Ukraine

National-scale demand for mental health support is outpacing clinical capacity.

Pressure timeline

Phase 1

Long-term stress accumulation

Phase 2

Rapid escalation in demand

Now

Capacity gap in diagnosis & monitoring

Crisis signal

Demand curve keeps rising while clinical supply flattens.

9–15M

Need psychosocial help

3–4M

Need medication

69%

Psychiatrist burnout

2–3 yrs

Time to diagnosis

Higher suicide mortality

Designed to be

Objective

Accurate

Evidence-based

Accessible

Fast

What AIREST is

  • SaMD Class IIa (EU MDR)
  • Screens PTSD, depression, anxiety, mixed anxiety-depressive disorder
  • 10–15 min protocol (target 5× faster than psychiatrist consult)
  • Target performance AUC/ROC 0.85–0.93

Clinical scope

PTSD / Anxiety

Protocol length

10–15 min

Speed target

5× faster

Target AUC

0.85–0.93

How it works

01

Step 1

Open a secure link

02

Step 2

Complete 10–15 min protocol

03

Step 3

Receive risk + interpretation

Controlled speech
Free speech
Sustained phonation
Attention-bias slides

Compliance-ready

MDR / AI Act
ISO 14155
ISO 13485
ISO 14971
GDPR

Value proposition

For patients

  • Fast state insight + recommendations
  • Reduced stigma

For clinics

  • Triage speed 6×
  • Objective metrics for diagnosis
  • Reduced psychiatrist burnout
  • Improved treatment monitoring

For society

  • Prevent ~20–26 suicides per 100k screened
  • Save €1–4M productivity/taxes
  • €281–563M resource savings
  • Early diagnosis: -20% costs, -30% hospital days

Market opportunity

EU losses from mental disorders: €600B/year

€1 invested in screening saves €3–5

Insurers seek lower payouts

Digital health growth +18–22% YoY

TAM €625,000,000 SAM €277,500,000 SOM (1–3 years) €6,000,000

Traction

TRL
TRL 4
Q
Publications (Q1–Q3)
H
Horizon grant applications
AI
AI for Ukraine Recovery wins
UCU
UCU, Academ.City

Roadmap

M1–5: Regulatory & ethics prep

M6–17: Clinical study & data

M17–22: Build AI platform

M22–24: Clinical product

M24+: EU scaling

Funding & partnerships

€600k
Months 1–24: clinical study, AI platform, TRL 6/7, first pilots
€1.0M+
Ukraine GTM: SaMD certification, TRL 8/9, hospital & insurer pilots
€5.0M+
EU GTM: localization, certification, commercial pilots

Team

CEO

CEO

Illia Ogoltsov

Project architect bridging deep learning research and product delivery.

CTO

CTO

Nikita Basenko

Leads multimodal feature engine and backend architecture.

COO

COO

Oleksandra Yakovleva

Leads psychosocial programs, clinical sites, and workflows.

CRO

CRO / CBO

Bohdan Haran

PTSD researcher with veteran community access; leads studies and stakeholder engagement.

SR

Senior Researcher

Tetiana Lahuta

PhD-level PTSD biomarker researcher focused on interpretable detection.

SR

Senior Researcher

Ostap Kalapun

Medical computer vision & MLOps; leads face/gaze and attention-bias modules.

SEC

Cybersecurity

Yurii Ladonia

Leads security architecture, threat modeling, and data-protection controls.

Thank you

LLC AIREST • Contact us for pilots and partnerships